Regulation of 11β-hydroxysteroid dehydrogenase type II expression in the renal epithelial cells

Endocrine Research

Volumn 29, Issue 2, 2003, Pages 211-216

  Lecybyl, R ^a   Rubis, B ^a   Krozowski, Z ^b   Trzeciak, Wieslaw H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; MESSENGER RNA; METHIONINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE C; SULFUR 35; ENZYME ACTIVATOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; KIDNEY EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS; ANIMAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GENETICS; KIDNEY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATORS; EPITHELIAL CELLS; FEMALE; FORSKOLIN; GENE EXPRESSION REGULATION; KIDNEY; PROTEIN KINASE C; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 0038345168     PISSN: 07435800     EISSN: None     Source Type: Journal    
DOI: 10.1081/ERC-120022308     Document Type: Article

References (13)

1. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994; 105:R11-R17.
2. Horisberger JD, Rossier BC. Aldosterone regulation of gene transcription leading to control of ion transport. Hypertension 1992; 19:221-227.
3. White PC. Inherited forms of mineralocorticoid hypertension. Hypertension 1996; 28:927-936.
4. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10:394-399.
5. Roland BL, Funder JW. Localization of 11 beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology 1996; 37:1123-1128.
6. Monder C. Corticosteroids, receptors and the organ specific functions of 11 beta-hydroxysteroid dehydrogenase. FASEB J 1991; 5:3047-3054.
7. Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K, Krozowski ZS. Localization of 11 beta-hydroxysteroid dehydrogenase type II in epithelial tissues. J Clin Endocrinol Metab 1996; 81:3244-3248.
8. Smith RE, Li KX, Andrews RK, Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 1997; 138:540-547.
9. Li KX, Smith RE, Ferrari P, Funder JW, Krozowski ZS. Rat 11 beta-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney. Mol Cell Endocrinol 1996; 120:67-75.
10. Trzeciak WH, LeHoux JG, Waterman MR, Simpson ER. Dexamethasone inhibits corticotropin-induced accumulation of CYP11A and CYP17 messenger RNAs in bovine adrenocortical cells. Mol Endocrinol 1993; 7:206-213.
11. Lecybyl R, Jagodzinski PP, Krozowski ZS, Trzeciak WH. Regulation of 11 beta-hydroxysteroid dehydrogenase type II in rat adrenocortical cells. Endocr Res 1998; 24:643-647.
12. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 1995; 80:2203-2209.
13. Hirasawa A, Hashimoto K, Tsujimoto G. Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats. Eur J Pharmacol 1994; 267:71-75.